These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7447416)

  • 21. [Antibiogram of mycobacteria for erythromycin, tetracycline and cotrimoxazole].
    Demoulin L; Médard M; Kellens J
    Pathol Biol (Paris); 1983 Mar; 31(3):195-7. PubMed ID: 6343976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum.
    Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):145-7. PubMed ID: 11858912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.
    Flynn CM; Kelley CM; Barrett MS; Jones RN
    J Clin Microbiol; 1997 Aug; 35(8):2083-6. PubMed ID: 9230386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
    Pajukanta R; Asikainen S; Forsblom B; Piekkola M; Jousimies-Somer H
    Oral Microbiol Immunol; 1994 Apr; 9(2):123-5. PubMed ID: 8008429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.
    Dalovisio JR; Pankey GA
    J Infect Dis; 1978 Mar; 137(3):318-21. PubMed ID: 632627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of Mycobacterium fortuitum to antibacterial agents as evaluated by disk diffusion and agar dilution methods.
    Orefici G; Scopetti F
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):402-5. PubMed ID: 6322817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of Ureaplasma urealyticum to ten chemotherapeutic agents.
    Sobetzko R; Hartmann AA; Elsner P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):245-50. PubMed ID: 2973712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of susceptibility of Haemophilus influenzae to antibiotics (other than beta-lactams) by using HTM gelose (Haemophilus test medium)].
    Dabernat H; Seguy M; Delmas C
    Pathol Biol (Paris); 1993 Sep; 41(7):596-603. PubMed ID: 8255611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.
    Jones RN; Barry AL; Fuchs PC; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1979 Dec; 16(6):823-8. PubMed ID: 533262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial susceptibility of Ureaplasma urealyticum.
    Davis JW; Hanna BA
    J Clin Microbiol; 1981 Feb; 13(2):320-5. PubMed ID: 7204548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of streptococci to newer tetracyclines and cephalosporins and to other antimicrobial agents.
    Freundlich LF; Zanfordino E; Rosenthal SL
    Am J Med Technol; 1979 Oct; 45(10):835-9. PubMed ID: 40435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T; Casals JB; Eng J
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria.
    Ho YI; Chan CY; Cheng AF
    J Antimicrob Chemother; 1997 Jul; 40(1):27-32. PubMed ID: 9249201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.
    Swenson JM; Thornsberry C; McCroskey LM; Hatheway CL; Dowell VR
    Antimicrob Agents Chemother; 1980 Jul; 18(1):13-9. PubMed ID: 6998374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibilities of Gardnerella vaginalis.
    Kharsany AB; Hoosen AA; Van den Ende J
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2733-5. PubMed ID: 8109944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1981 Aug; 20(2):247-51. PubMed ID: 7283421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.